As a scientist, Dr. Serafini enjoys the pursuit of innovation in his scientific research – as a lawyer, he uses his scientific background to strengthen his clients’ positions. He assists his clients in obtaining, protecting, and enforcing their intellectual property rights, especially in the areas of immunology, molecular biology, chemistry, antibody engineering and therapeutics, vaccines, stem cell technologies, molecular genetics, genomics, proteomics and protein chemistry, pharmaceuticals, medical therapeutics, nanotechnology, clean energy, medical diagnostics, and personalized medicine.

In over twenty years of practice, Dr. Serafini has focused on strategic and comprehensive intellectual property counseling and management for biotechnology, biopharmaceutical, and other diverse life sciences clients. He fully engages with his clients, so he knows not only his clients’ wants and needs, but also how to best realize his clients’ goals given the pressures of business, the innovations of science, and the connections of the global community.

Dr. Serafini's practice includes preparing and prosecuting U.S. and international patents; performing due diligence and freedom to operate analyses associated with mergers and acquisitions, venture capital and other private and public financings; drafting opinions on patentability, non-infringement and patent validity; product development counseling; supporting patent infringement litigation, post grant proceedings, and International Trade Commission investigations.

Dr. Serafini guided the development of the intellectual property estate for Medarex’s ipilimumab (Yervoy™), a first-in-class monoclonal antibody and checkpoint inhibitor directed at CTLA-4, a protein receptor and key target in cancer immunotherapy.

Dr. Serafini is also an Adjunct Professor of Law at the University of Washington (UW) School of Law teaching advanced courses in intellectual property. He also advises and mentors law students participating in independent study programs and law clinics, including the UW School of Law Entrepreneurial Law Clinic.

Dr. Serafini is a Director on the Life Science Washington (LSW) Board. LSW, formerly the Washington Biotechnology & Biomedical Association, is an independent, non-profit trade association serving the life sciences industry in the state of Washington. LSW members include organizations engaged in, or supportive of, the research, development and commercialization of life science technologies. Dr. Serafini was recognized as the Volunteer of the Year at the 2013 Governor's Life Science Summit and WBBA Annual Meeting.

Dr. Serafini is a Director on the Antibody Society of Korea Board (“ASK”; Republic of Korea).

He is also President of the Board of Directors for the Washington Rush (WA Rush) Youth Soccer Club. WA Rush is committed to the development of healthy youth through the game of soccer.